September 27, 2016 9:53 AM ET

Biotechnology

Company Overview of Idera Pharmaceuticals, Inc.

Executive Profile

James A. Geraghty J.D.

Chairman of The Board, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee, Idera Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 10 Board Members in 10 different organizations across 14 different industries.

See Board Relationships
61$212,233

Background

Mr. James A. Geraghty, also known as Jim, J.D. serves as a Director of Fulcrum Therapeutics, Inc. He has been the Chairman of Idera Pharmaceuticals, Inc. since July 2013. He has been the Chairman of rEVO Biologics, Inc. since April 2014. Mr. Geraghty served as Chairman of rEVO Biologics, Inc. from January 1998 to July 2001. He has been Chairman of the Board of Juniper Pharmaceuticals, Inc. since July 7, 2015 and its Director since March 26, 2015. He has been a Director ...

Corporate Headquarters

167 Sidney Street
Cambridge, Massachusetts 02139

United States

Phone: 617-679-5500
Fax: 617-679-5592

Board Members Memberships

Chairman and Member of Nominating & Corporate Governance Committee
Director
Director
Director
2013-Present
Chairman of The Board, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee
2014-Present
Trustee
2014-Present
Independent Director, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee
2015-Present
Chairman, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee
2016-Present
Director

Education

MS
University of Pennsylvania
BA
Georgetown University
JD
Yale Law School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$84,500
Total Calculated Compensation$212,233
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Idera Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.